Table 1.

Incidence, YLD, death and YLL in patients with NCDs in 2017.^4-7,10,11

^{13,16,17,19-22,31,32}

	Incidencea (thousands)		YLDsa (thousands)		All-age deathsa (thousands)		All-age YLLsa (thousands)		Risk of VPD
	Global	India	Global	India	Global	India	Global	India
All NCDs	10,813,563	1,854,283	678,294	113,677	41,071	4,679	872,602	141,269	Increased Increased severity of complications8-15,18
CVD	72,721	7,385	35,697	3,734	17,790	2,217	330,173	61,699	2x more likely to develop herpes zoster10 Higher risk of hospitalization or death due to influenza11 Poorer outcomes when hospitalized with pneumonia13
Stroke	11,931	1,137	18,695	1,508	6,167	656	113,356	16,530
Chronic respiratory disease	62,161	8,759	44,312	9,546	3,914	833	68,005	18,976	3–16x increased risk of pneumococcal disease31 Rhino/enteroviruses and influenza in 60–80% and 22–64% of adults with asthma and COPD exacerbations, respectively19,32 Influenza associated with worse outcomes and excess morbidity and mortality in patients with COPD20
COPD	18,476	3,706	30,612	7,724	3,198	-	50,990	-
Asthma	43,123	4,966	10,623	1,164	495	-	12,140	-
Diabetes	22,936	3,639	38,575	5,640	1,370	228	29,300	5,952	Risk of hepatitis B infection 43% higher21 Increased risk of premature death from infectious diseases22 Increased risk of hospitalization and death due to influenza17
CKD	19,736	3,101	7,306	1,246	1,230	224	28,509	6,294b	Increased Associated with worse outcomes16

CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; NCD, non-communicable disease; VPD, vaccine-preventable disease; YLD, years lived with disability; YLL, years of life lost.

^aNumbers rounded to the nearest thousand; ^bNumbers are reported for renal failure listed under NCD in the source reference.